New study tests clotting drug to stop dangerous bleeding after birth
NCT ID NCT07157423
First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 34 times
Summary
This study is testing the safety of a medicine called eptacog alfa (NovoSeven) for women in India who have severe bleeding after giving birth. 64 women who do not respond to standard treatments will receive one or two doses of the drug. Researchers will monitor for blood clots, allergic reactions, and other serious side effects over about a month.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE POSTPARTUM HAEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
All India Institute of Medical Sciences_New Dehli
RECRUITINGNew Delhi, National Capital Territory of Delhi, 110029, India
-
Calicut Medical College
RECRUITINGKozhikode, Kerala, 673008, India
-
Calicut Medical College
NOT_YET_RECRUITINGKozhikode, Kerala, 673008, India
-
KLE Belgum
RECRUITINGBelagavi, Karnataka, 590010, India
-
KLE Belgum
NOT_YET_RECRUITINGBelagavi, 590010, India
-
Post Graduate Institute of Medical Education & Research_Chandigarh
RECRUITINGChandigarh, 160012, India
-
Post Graduate Institute of Medical Education & Research_Chandigarh
NOT_YET_RECRUITINGChandigarh, 160012, India
-
SMS Hospital
RECRUITINGJaipur, Rajasthan, 302004, India
-
SMS Hospital
NOT_YET_RECRUITINGJaipur, Rajasthan, 302004, India
-
Seth GS Medical College & KEM Hospital
RECRUITINGMumbai, Maharashtra, 400012, India
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
eptacog alfa (NovoSeven)
What this could lead to
If successful, this could confirm that eptacog alfa is a safe option for stopping severe bleeding after childbirth in Indian women.
What could go wrong
This is a small, single-arm safety study with no comparison group, so it cannot prove the drug works better than standard care. There is a risk of blood clots or allergic reactions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.